[1] Pedicini P,Strigari L,Benassi M. Critical dose and toxicity index of organs at risk in radiotherapy:Analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer[J]. Med Dosim, 2014,39:23-30. [2] Weiss E, Fatyga M, Wu Y, et al. Dose escalation for local advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost[J].Int Radiat Oncol Bilo Phys,2013, 86(3):414-419. [3] Weichselbaum RR, Hellman S. Oligometastasis revisited[J].Nat Rev clin Oncol, 2011, 8(16):378-382. [4] 李凤虎,卢冰,付和谊,等.546例Ⅳ期非小细胞肺癌远处转移特点的放疗意义分析[J].中华放射肿瘤学杂志, 2012, 21(2):122-125. [5] 李瑞宁,李晓敏.Ⅳ期非小细胞肺癌寡转移放射治疗的理论及研究现状[J].中华肿瘤防治杂志, 2016, 23(18):1272-1276.. [6] Simone Marnitz, Martin Stuschke, Jorg Bohsung, et al. Intraindividual Comparison of Conventional Three-Dimensional Radiotherapy and Intensity Modulated Radiotherapy in the Therapy of Locally Advanced Non-Small Cell Lung Cancer[J]. 2002,178:651-658. [7] Allison Ashworth, George Rodrigues, Gabriel Boldt, et al. Is there an oligometastatic state in non-small cell lung cancer A systematic review of the literature[J].Lung Cancer, 2013, 82:197-203. [8] K JI, L J ZHAO, W S LIU, et al. Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer:a retrospective clinical study[J]. Br J Radiol, 2014, 87:1-7. [9] Margriet K, Wilma U, Jasper N, et al. Acute Esophagus Toxicity in Lung Cancer Patients After Intensity Modulated Radiation Therapy and Concurrent Chemotherapy[J]. Int J Radiation Oncol Biol Phys, 2012:1-6. [10] Hyejoo Kang, Ellen Yorke, Jie Yang, et al. Evaluation of tumor motion effects on dose distribution for hypofractionated intensity modulated radiotherapy of non-small cell lung cancer[J]. Appl Clin Med Phys, 2010, 11(3):1-15. [11] Anhui Shi, Guangying Zhu, Hao Wu, et al. Analysis of clinical and dosimetric actors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. Radiation Oncology,2010, 35(5):1-8. [12] 张伟,吴磊,樊林.调强适形放射治疗联合TP化疗方案治疗晚期非小细胞肺癌的临床研究[J].中华肿瘤临床与康复, 2014, 12(24):1413-1415. [13] 王绿化.放射治疗在转移性肺癌中的应用[J].中国肿瘤内科进展,中国肿瘤医师教育年会.2014,07.03. [14] 欧阳伟炜,卢冰.IV期NSCLC化疗同期三维放疗的预后再分析[J].中华放射肿瘤学,2014,23(6):485-489. [15] 苏胜发,卢冰,马筑,等.非小细胞肺癌化疗同期调强放疗靶区变化规律的临床分析[J].中国癌症防治杂志, 2013, 5(3):231-235. [16] 苏胜发,卢冰,胡银祥,等.NSCLC单器官转移化疗同期原发及转移灶放疗的临床观察[J].中华肿瘤防治杂志, 2013, 20(14):1102-1105. [17] 欧阳伟炜,卢冰,胡银祥,等.Ⅳ期NSCLC同期放化疗单中心前瞻性生存分析[J].中华肿瘤防治杂志, 2013, 20(16):1262-1266. [18] 张波,卢冰,苏胜发,等.Ⅳ期非小细胞肺癌化疗同期胸部三维放疗的前瞻性临床研究(四)——近疗效对生存的影响[J].中华放射肿瘤学杂志, 2012,21(1):29-33. [19] 吕家华,李涛,刘丽,等.Ⅳ期寡转移NSCLC同期放化疗后巩固化疗前瞻性Ⅱ期临床研究[J].中华放射肿瘤学杂志,2016,24(6):611-614. [20] 郑远达,陈建祥,林清认,等.肺部原发灶姑息性放射治疗在Ⅳ期非小细胞肺癌中的作用[J].肿瘤学杂志, 2016,22(10):832-837. [21] 张矛,孙涛,崔洪霞,等.原发灶及转移灶放疗在Ⅳ期寡转移非小细胞肺癌中的疗效分析[J/CD].中华临床医师杂志,2017,11(4):543-549.
